Skip to main content

23 January 2026

Last updated: Friday 23 January 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

AAV-based gene therapies poised for uplift

Saturday 7 December 2024

Interviewee/Contributor

Stéphane Degove

Organisation

Atamyo Therapeutics SAS

Organisations

Massachusetts General Hospital
Amyl Therapeutics BV
United Therapeutics Corp and Sidley Austin LLP
Marks and Clerk Solicitors LLP
Quotient Therapeutics Ltd
Shore Capital
Terumo Blood and Cell Technologies
Leyden Laboratories BV
Stanford University School of Medicine
SSquared Consulting

Interviewees and Contributers

Andy Smith
Martin Fussenegger
Richard Jones and Stephen Witte
Philipp Spycher
Charles Large
Darrin Disley
Jane Buus Laursen
Michael Valenzuela
Jennifer Hannesschlager
Michael Hunt

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

German biotech DISCO Pharmaceuticals appoints CEO

Monday 19 January 2026

argenx in CEO transition

Monday 19 January 2026

PureTech Health appoints CEO

Monday 19 January 2026

New CEO at Tacalyx

Monday 19 January 2026

Tubulis appoints oncology expert as CMO

Monday 19 January 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form